Kim N Chi Selected Research

Kim N Chi Research Topics

Disease

184	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 09/2003
76	Neoplasms (Cancer) 12/2023 - 09/2003
30	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2009
23	Disease Progression 12/2023 - 01/2015
18	Pain (Aches) 12/2023 - 10/2004
14	Fatigue 12/2023 - 02/2008
8	Hypertension (High Blood Pressure) 01/2023 - 05/2011
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2009
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2023 - 04/2010
5	Febrile Neutropenia 01/2023 - 08/2005
5	Exanthema (Rash) 01/2023 - 01/2019
5	Carcinoma (Carcinomatosis) 01/2020 - 08/2014
4	Neutropenia 01/2020 - 08/2005
4	Circulating Neoplastic Cells 12/2018 - 05/2015
3	Adenocarcinoma 01/2023 - 08/2012
3	Transitional Cell Carcinoma 02/2006 - 10/2002
2	Anemia 01/2023 - 01/2020
2	Sepsis (Septicemia) 01/2022 - 11/2017
2	Nausea 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 10/2021 - 01/2019
2	Seizures (Absence Seizure) 11/2019 - 09/2012
2	Lymphatic Metastasis 07/2017 - 09/2010
2	Hypokalemia 01/2017 - 05/2011
2	Fever (Fevers) 09/2010 - 02/2008
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2010 - 12/2005

Drug/Important Bio-Agent (IBA)

41	Docetaxel (Taxotere)FDA Link 03/2024 - 10/2004
39	AndrogensIBA 12/2023 - 02/2005
27	enzalutamideIBA 11/2023 - 09/2012
27	Abiraterone AcetateIBA 01/2023 - 05/2011
27	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2004
26	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 06/2004
25	abirateroneIBA 11/2023 - 05/2011
23	Hormones (Hormone)IBA 04/2024 - 06/2004
17	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 12/2016
17	Biomarkers (Surrogate Marker)IBA 11/2022 - 08/2012
16	apalutamideIBA 04/2024 - 01/2019
13	Circulating Tumor DNAIBA 01/2023 - 11/2017
13	Cell-Free Nucleic AcidsIBA 11/2022 - 05/2015
12	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 10/2004
10	ClusterinIBA 01/2016 - 06/2004
9	OGX-011IBA 11/2017 - 09/2005
7	AntigensIBA 03/2024 - 12/2020
6	PlatinumIBA 11/2020 - 01/2016
5	olaparibIBA 11/2023 - 01/2020
5	bicalutamide (Casodex)FDA LinkGeneric 01/2023 - 08/2012
5	Testosterone (Sustanon)FDA Link 01/2023 - 01/2016
5	taxaneIBA 01/2023 - 01/2021
5	Antisense OligonucleotidesIBA 08/2013 - 06/2004
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2013
4	niraparibIBA 01/2023 - 01/2021
4	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2017
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 08/2014
4	PlacebosIBA 01/2020 - 01/2018
4	Alkaline PhosphataseIBA 10/2019 - 01/2016
3	177Lu-PSMA-617IBA 03/2024 - 01/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
3	antiarrhythmic peptide (AAP)IBA 01/2023 - 01/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 07/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 07/2005
3	RamucirumabIBA 01/2020 - 01/2016
3	Radium-223IBA 10/2019 - 09/2017
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 10/2004
3	cabazitaxel FDA Link 10/2018 - 06/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2018 - 05/2015
3	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 10/2002
3	Calcitriol (Calcijex)FDA LinkGeneric 01/2008 - 11/2006
2	Lutetium-177IBA 03/2024 - 01/2023
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 10/2021
2	hydrogen sulfite (bisulfite)IBA 01/2023 - 01/2020
2	ChromatinIBA 01/2023 - 11/2017
2	ipatasertibIBA 01/2023 - 10/2021
2	Androgen Antagonists (Antiandrogens)IBA 01/2023 - 08/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	TabletsIBA 11/2019 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 10/2019 - 12/2009
2	cabozantinibIBA 01/2019 - 01/2016
2	Sunitinib (Sutent)FDA Link 12/2016 - 02/2009
2	MicroRNAs (MicroRNA)IBA 04/2013 - 08/2012
2	Phosphotransferases (Kinase)IBA 08/2012 - 06/2004
2	Gemcitabine FDA Link 04/2010 - 02/2006
2	Carboplatin (JM8)FDA LinkGeneric 04/2010 - 10/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 12/2009
2	VA 061 (VA061)IBA 06/2008 - 01/2008
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Interleukin-4 (Interleukin 4)IBA 03/2024
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2023

Therapy/Procedure

141	Castration 03/2024 - 09/2008
80	Therapeutics 04/2024 - 06/2004
37	Drug Therapy (Chemotherapy) 01/2023 - 02/2005
6	Radiotherapy 03/2023 - 09/2003
5	Immunotherapy 01/2023 - 01/2015
4	Prostatectomy (Retropubic Prostatectomy) 05/2017 - 09/2005
3	Neoadjuvant Therapy 05/2017 - 12/2007
2	Aftercare (After-Treatment) 01/2023 - 01/2019
1	Investigational Therapies (Experimental Therapy) 11/2023